Key Highlights
- Series C Funding: GreenLight Biosciences closed its Series C funding round, with an additional $25 million from Just Climate.
- Product Milestone: Calantha™, the first RNA-based crop protection spray, successfully launched in the U.S. and Ukraine.
- Pipeline Development: Funding to support commercialization of Norroa™ and expansion of Fortivance™.
- International Expansion: New Agricultural Research Station in Seville, Spain to serve as EU innovation hub.
- Sustainability Focus: Reinforcing commitment to environmentally responsible agricultural biosolutions.
GreenLight Biosciences Series C Funding to Drive Growth
GreenLight Biosciences, Inc. announced the successful completion of its Series C funding round, bringing in $25 million in new capital. The funding was provided by Just Climate, a mission-driven investor focused on high-impact climate solutions, with participation from both new and existing shareholders.
Dr. Andrey Zarur, CEO of GreenLight Bio, stated: “This strategic investment from Just Climate and others represents a powerful endorsement of our RNA platform’s potential to revolutionize agriculture while addressing environmental challenges including pollinator health.”
Calantha™ Gains Commercial Traction
GreenLight Bio’s flagship product, Calantha™, is the first-ever registered RNA-based crop protection spray. Registered in both the United States and Ukraine, Calantha™ provides potato growers with an alternative to conventional chemical pesticides, offering comparable efficacy with enhanced environmental safety.
Advancing GreenLight Bioscience’s Product Pipeline
The funding will accelerate development and commercialization of:
- Norroa™ – An RNA solution targeting varroa mites in honeybee colonies. U.S. registration is pending.
- Fortivance™ – A novel adjuvant designed to enhance the performance of agricultural treatments and reduce environmental impact.
According to data from the Honey Bee Health Coalition, U.S. beekeepers experienced honeybee colony losses averaging 62% between June 2024 and February 2025, underscoring the urgency for solutions like Norroa™.
GreenLight Bio’s Global Expansion Strategy
GreenLight Bio continues to scale its international presence, focusing on Latin America and Europe. Its new Agricultural Research Station in Seville, Spain, serves as a European hub for innovation and collaborative research into sustainable agricultural practices.
Reinforcing Sustainability Leadership
With this latest round of funding, GreenLight Bio plans to strengthen its role as a sustainability leader. The company’s RNA platform provides an alternative to chemical pesticides, supporting food production while preserving pollinator health and biodiversity.
Eduardo Mufarej, Co-Chief Investment Officer at Just Climate, commented: “GreenLight Biosciences exemplifies the type of innovative enterprise that can deliver transformative environmental impact while building sustainable commercial success.”
GreenLight Bio remains focused on its mission to build a safer, more equitable food system through nature-based solutions.
1 Comment